Metraipolis › archive › dc_dbd520717bbc

Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish… — Europe PMC PMID:42449669

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449669
DOI
10.3390/cancers18132127
License (as archived)
solo-consultazione
Archived
2026-10-18T14:46:37.091Z
SHA-256 of the archived text
1ff9445fa33a40f90b0c3ec22c91341647d271364378dfec764ff61a068e5b0a
Stable URL of this page
https://metraipolis.com/documento/dc_dbd520717bbc

How to cite

Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish… — Europe PMC PMID:42449669 — Europe PMC (en), https://europepmc.org/article/MED/42449669 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbd520717bbc (Metraipolis archive dc_dbd520717bbc, sha256 1ff9445fa33a40f90b0c3ec22c91341647d271364378dfec764ff61a068e5b0a)
BibTeX
@misc{dcdbd520717bbc,
  title = {Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish… — Europe PMC PMID:42449669},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449669},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbd520717bbc; sha256 1ff9445fa33a40f90b0c3ec22c91341647d271364378dfec764ff61a068e5b0a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449669. Agents can read the archived copy with the MCP tool read_document.